Cary Street Partners Investment Advisory’s PetMed Express PETS Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-500	Closed	-$5.13K	–	1470
2023 Q3	$5.13K	Hold	500	–	–	﹤0.01%	1472
2023 Q2	$6.89K	Hold	500	–	–	﹤0.01%	1328
2023 Q1	$8.12K	Hold	500	–	–	﹤0.01%	1202
2022 Q4	$8.85K	Buy	+500	New	+$9.93K	﹤0.01%	1191

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cary Street Partners Investment Advisory's PETS Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of PetMed Express (PETS) in Q4 2023, closing a stake of 500 shares — an estimated $5.13K sold.

Cary Street Partners Investment Advisory first reported a position in PETS in Q4 2022 and held it in 4 quarters. The position peaked at $8.85K in Q4 2022. 130 funds tracked by Wall St. Rank hold PETS as of Q4 2023.

Cary Street Partners Investment Advisory reported no remaining PetMed Express position as of Q4 2023 after selling out during the quarter.
Cary Street Partners Investment Advisory sold 500 PetMed Express shares in Q4 2023, an estimated $5.13K.
Cary Street Partners Investment Advisory first reported a position in PetMed Express in Q4 2022 and held it in 4 quarters.
Cary Street Partners Investment Advisory's PetMed Express position peaked at $8.85K in Q4 2022.
130 funds tracked by Wall St. Rank held PetMed Express as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.